SILO vs XLU
Silo Pharma Inc (SILO) versus XLU (XLU) — a side-by-side from cached financials, not a winner call.
Silo Pharma Inc (SILO) is a biotechnology company listed on US.
XLU (XLU) common stock.
Latest reported SILO revenue for 2026-06-30 was $18.0K. Net income was -$2.5M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. SILO currently screens at market cap $4.4M.
XLU does not have a complete income-statement cache yet.
SILO currently screens at market cap $4.4M. XLU currently screens at market cap $0.
Not investment advice. Open the SILO and XLU stock pages for the full models.
Not investment advice.